FDA Lifts Clinical Hold on Pharvaris’ HAE Treatment
The FDA has cleared Pharvaris' investigational drug for clinical trials. This is great news for patients with hereditary angioedema (HAE), a rare and potentially life-threatening condition. The drug has been on hold since last year